Publication | Closed Access

Flurbiprofen derivatives as novel α-amylase inhibitors: Biology-oriented drug synthesis (BIODS), in vitro, and in silico evaluation

Medicinal ChemistryPharmaceutical ScienceDerivativesNovel α-Amylase InhibitorsBiochemistryFlurbiprofen DerivativesMedicineNatural SciencesRational Drug DesignPharmacological AgentDrug DevelopmentBiology-oriented Drug SynthesisPharmacologyPharmaceutical ChemistryDrug Discovery